Recent news and posts
NHS Accelerated Access Collaborative published "Our year in focus 2019/20" report
In February 2021, NHS Accelerated Access Collaborative (AAC) published an "Our year in focus 2019/20" report.
In 2019/20, AAC programs supported over 2,500 innovations, delivered patient benefits estimated to include 125,000 fewer days spent in the hospital, and saved the NHS more than £50 million.
The report provides information regarding AAC achievements in six priority areas: innovation service, demand signaling, horizon scanning, world-leading testing infrastructure, adoption & spread, funding strategy.
Also, future objectives were identified:
- The MedTech Funding Mandate will be launched in April 2021 to accelerate patient access to clinically proven NICE-approved medical devices
- The Innovation Service will go live next summer, making it easier for innovators to navigate the health innovation system and, ultimately, enabling innovations to get to patients faster
- The Artificial Intelligence in Health and Care Award will grant funding to Phase 2 applicants in May 2021, supporting the acceleration of testing and evaluation of the most promising AI technologies for the NHS. The next competition opens in summer 2021
- In the Rapid Uptake Products program, AAC will be delivering four workstreams to accelerate the adoption and spread of proven innovations. The workstreams cover ten products across asthma diagnosis and management, cancer prevention, and lipids management
See the full details here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).